Evidence map›Paper›PMID 20676912›Full record

ArticleJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy2011

Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age.

Naoyuki Miyashita, Takaya Maruyama, Tetsu Kobayashi, Hiroyasu Kobayashi, Osamu Taguchi, Yasuhiro Kawai, Tetsuya Yamaguchi, Kazunobu Ouchi, Mikio Oka

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Update on the Epidemiology of Macrolide-ResistantInfectious disease reports · 2021
    Review
  2. Review
  3. Article
  4. Mycoplasma pneumoniae pneumonia in children.Korean journal of pediatrics · 2012
    Article
  5. Article
  6. Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Naoyuki MiyashitaDepartment of Respiratory Medicine, Kawasaki Medical School, Kurashiki, Okayama, Japan. nao@med.kawasaki-m.ac.jp
Takaya Maruyama
Tetsu Kobayashi
Hiroyasu Kobayashi
Osamu Taguchi
Yasuhiro Kawai
Tetsuya Yamaguchi
Kazunobu Ouchi
Mikio Oka
Kawasaki Medical School · JPMie University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A macrolide-resistant Mycoplasma pneumoniae strain was isolated from two patients with community-acquired pneumonia. The pneumonia severity score of both patients was mild, and rapid clinical improvement was seen after administration of fluoroquinolone. Clinical features of macrolide-resistant M. pneumoniae pneumonia were identical to those of macrolide-sensitive M. pneumoniae pneumonia. An A-to-G transition at position 2063 and 2064, respectively, in domain V of the 23S rRNA gene was identified. The minimum inhibitory concentration of erythromycin of these isolates was greatly elevated. In Japan, macrolide-resistant M. pneumoniae infections are common in pediatric patients but not in adults. However, physicians should pay attention to macrolide-resistant M. pneumoniae not only in children but also in adults.

Indexed as

AdolescentAdultCommunity-Acquired InfectionsDNA, BacterialDrug Resistance, BacterialErythromycinFemaleFluoroquinolonesHumansLungMaleMicrobial Sensitivity TestsMycoplasma pneumoniaePneumonia, MycoplasmaPolymerase Chain ReactionRadiographyDNA, BacterialErythromycinFluoroquinolonesRNA, Ribosomal, 23S

Identifiers

PMID20676912
OpenAlexW2021216359

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.